リウマチ病セミナー IV

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,850 円(税込)

購入する

商品紹介

他の分野におけると同様、リウマチ学の領域でも急速度で新しい知見が集積して、これを消化し、臨床の場で患者それぞれに対応できるようになるのは容易なことではないと思われる。この本がその一助にでもなればというささやかな願いが届けば、望外の喜びとするところである。

目次

  • 表紙
  • 執筆者一覧
  • 序文
  • 目次
  • 炎症リウマチ
  • Schonlein-Henoch紫斑病, 診断基準
  • IgA nephropathy
  • cutaneous polyarteritis nodosa
  • 非侵食性RA
  • 寛解導入剤は寛解をもたらすか? 殊に初期RAに対して
  • ヘルペスウイルスと骨関節症状
  • HIV感染とリウマチ症状
  • 骨関節, 脊椎, 神経
  • 脊椎のalgodystrophy
  • オステオポローシスとエストロジェン
  • 前胸壁の痛み
  • 股関節の原発性chondrolysis
  • membranous lipodystrophy(膜形成脂肪異栄養症)
  • 手根不安定症
  • 検査法
  • 肩関節軟部組織の画像診断: 腱板および周囲組織を中心に
  • 薬剤評価のためのOAのX線計測
  • 腫瘍マーカーと骨関節症状
  • 生物学的反応
  • メタロプロテイナーゼとイソヒビター
  • 関節破壊マーカーとRA, OA
  • C-ANCAとP-ANCA
  • T細胞レセプター
  • HLA-B27 in 1992
  • リウマチ学の新しい研究方法-遺伝子導入による実験法-
  • 治療と副作用
  • 新しい抗リウマチ剤-ミゾリピン, サラゾスルファピリジン, アクタリットー
  • RA治療におけるモノクローナル抗体
  • インターフェロンとリウマチ病
  • 胃粘膜保護剤
  • リウマチ病治療におけるシクロスポリン
  • 急性脊髄損傷に対するステロイドの効果
  • RAの手の変形とorthosis
  • 手術
  • 肩の人工関節の進歩
  • 索引(リウマチ病セミナーI～IV)
  • DRUG INFORMATION
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.13 掲載の参考文献
1) Mills JA, Michel BA, Bloch DA, et al:The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114-1121, 1990
PubMed
2) Fauci AS, Leavitt RY:Vasculitis. In Arthritis and allied conditions(Ed, McCarty DJ, Koopman WJ), pp.1301-1322, Philadelphia, Lea and Febiger, 1993
 
3) Fauci AS, Leavitt RY:Vasculitis. In Arthritis and allied conditions(Ed, McCarty DJ), pp.1166-1188, Philadelphia, Lea and Febiger, 1989
 
4) Goldbloom RB, Drummond KN:Anaphylactoid purpura with massive gastrointestinal hemorrhage and glomenrulonephritis. Am J Dis Child 116:97-102, 1968
PubMed
5) Austin HA, Balow JE:Henoch-Schonlein nephritis:prognostic features and the challenge of therapy. Am J Kidney Dis 2:512-520, 1983
PubMed
6) Turpin JC, Malpuech G, Lavignon A, et al:Les manifestations nerologiques du purpura rhumatoide. Pediatrie 28:185-192, 1973
 
7) 福井弘, 上辻秀和, 長尾大, 他:小児Schonlein-Henoch purpura に対する pasteurized factor XIII concentrateの臨床評価. 小児臨床41:2076-2084, 1988
 
8) Casanueva B, Rodriguez-Valverde V, Luceno A:Circulating IgA producing cells in the differential diagnosis of Henoch-Schonlein purpura. J Rheumatol 15:1229-1233, 1988
PubMed
9) Meadow SR, Scott DG:Berger disease. Henoch-Schonlein syndrome without the rash. J Pediatr 106:27-32. 1985
 
10) Heptinstall RH:Pathology of the kidney, pp741-791, London, Little, Brown and Co, 1983
 
11) Tsai C, Giangiacomo J, Zuckner J:Dermal IgA deposits in Henoch-Schonlein purpura and Berger's nephritis. Lancet:342-343, 1975
 
12) 吉野加津哉:血管性紫斑病(アナフィラクトイド紫斑病). 小児内科(増刊) 22:800-802, 1990
 
13) Allen DM, Diamond LK, Howell DA:Anaphylactoid purpura in children(Schonlein-Henoch syndrome). J Dis Child 99:833-854, 1960
PubMed
14) Singh SP, Misra GC, Prusty PK, et al:Tubercular lymphadenitis with purpura. J Indian MA 84:247-249, 1986
 
15) Lane JM:Vaccination and Henoch-Schonlein purpura. N Engl J Med 280:781, 1989
 
16) Ackroyd JF:Allergic purpura, including purpura due to foods, drugs and infections. Am J Med 14:605-632, 1953
PubMed
17) Rogers PW, Bunn SM, Kurtzman NA, et al:Schonlein-Henoch syndrome associated with exposure to cold. Arch Intern Med 128:782-786, 1971
PubMed
18) Miyagawa S, Dohi K, Hanatani M, et al:Anaphylactoid purpura and famillial IgA nephropathy. Am J Med 86:340-342, 1989
 
19) O'Donoghue DJ, Darvill A, Ballardie FW:Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schonlein purpura. J Clin Invest 88:1522-1530, 1991
 
20) 井川宣:IgA腎症. リウマチ病セミナーIV(七川歡次監修), pp.16-22, 大阪, 永井書店, 1993
 
21) Sakai H, Endoh M, Tomino Y, et al:Increase of IgA specific helper T α cells in patients with IgA nephropathy. Clin Exp Immunol 50:77-81, 1982
 
22) 伊藤克己, 鳴海福星, 川口洋, 他:紫斑病性腎炎の発生機序と長期予後. 小児内科 16:1301-1306, 1984
 
23) Knight JF, Harada T, Thomas MAB, et al:IgA rheumatoid factor and other autoantibodies in acute Henoch-Schonlein purpura. Contr Nephrol 67:117-120, 1988
 
24) Rostoker G, Pech MA, Prato SD, et al:Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schonlein purpura, Clin Exp Immunol 75:30-34, 1989
 
25) Davin JC, Malaise M, Foidart J, et al:Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schonlein purpura or IgA nephropathy. Kindney Int 31:1132-1139, 1987
 
26) Nyulassy S, Buc M, Sasinka M, et al:The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319-323, 1977
PubMed
27) Henriksson P, Hender U, Nilsson I M:Factor XIII(fibrin stabilising factor) in Henoch-Schonlein's purpura. Acta Pediatr Scand 66:273-277, 1977
 
28) Dalens B, Travade P, Labbe A, et al:Diagnostic and prognostic value of fibrin stabilising factor in Schonlein-Henoch syndrome. Arch Dis Child 58:12-14, 1983
PubMed
29) Cederholm B, Linne T, Wieslander J, et al:Fibronectin-immunoglobulin complexes in the early course of IgA and Henoch-Schonlein nephritis. Pediatr Nephrol 5:200-204, 1991
PubMed
30) Turi S, Nagy J, Haszon I, et al:Plasma factors influencing PG I2-like activity in patients with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 3:61-67, 1989
 
31) Saulsbury FT, Kirkpatrick PR, Bolton WK:IgA antineutrophil cytoplasmic antibody in Henoch-Schonlein purpura. Am J Nephrol 11:295-300, 1991
PubMed
32) O'Donoghue DJ, Nusbaum P, Noel LH, et al:Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 7:534-538, 1992
PubMed
33) Fogazzi GB, Pasquali S, Moriggi M, et al:Long-term outcome of Schonlein-Henoch nephritis in the adult. Clin Nephrol 31, 60-66, 1989
PubMed
34) Faull RJ, Woodroffe AJ, Aarons I, et al:Adult Henoch-Schonlein nephritis. Aust NZJ Med 17:396-401, 1987
 
35) Kauffmann RH, Houwert DA:Plasmapheresis in rapidly progressive Henoch-Schonlein in glomerulonephritis and the effect on circulating IgA immune complexes. Clin Nephrol 16:155-160, 1981
PubMed
36) Utani A, Ohta M, Shinya A, et al:Successful treatment of adult Henoch-Schonlein purpura with factor XIII concentrate. J Am Acad Dermatol 24:438-442, 1991
PubMed
37) 福井弘, 上辻秀和, 長尾大, 他:小児Henoch-Schonlein purpuraに対するpasteurized factor XIII concentrate投与後の長期経過. 小児科診療 45:2232-2238, 1992
 
38) 近藤和男, 梶谷喬, 光野正人, 他:空腸穿孔を併発したSchonlein-Henoch 紫斑病の1例. 小児科臨床33:87-90, 1980
 
39) Washio M, Nanishi F, Onoyama K, et al:Recurrence of Henoch-Schonlein purpura nephritis associated with truberculous pleuritis. Jap J Nephrology 30:25-27, 1988
 
40) Zeek PM:Periarteritis nodosa and other forms of necrotizing angiitis. N Eng J Med 248:764-72, 1953
 
41) 安倍達:ウェゲナー肉芽腫症. 綜合臨牀 41:862-865, 1992
 
42) 富野康日己, 堺秀人:過敏性血管炎, Schonlein-Henoch紫斑病. 日本臨牀43:2084-2088, 1985
 
43) Hunder GG, Arend WP, Bloch DA, et al:The American College of Rheumatology 1990 criteria for the classification of vasculitis:introduction. Arthritis Rheum 33:1065-1067, 1990
PubMed
44) Bloch DA, Michel BA, Hunder GG, et al:The American College of Rheumatology 1990 criteria for the classification of vasculitis:patients and methods. Artritis Rheum 33:1068-1073, 1990
 
45) Calabrese LH, Michel BA, Bloch DA, et al:The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108-1113, 1990
PubMed
46) Iian Y, Naparstek Y:Schonlein-Henoch syndrome in adults and children. Semin. in Arthritis Rheum 21:103-109, 1991
 
47) Michel BA, Hunder GG, Bloch DA, et al:Hypersensitivity vasculitis and Henoch-Schonlein purpura:a comparison between the 2 disorders. J Rheumatol 19:721-728, 1992
 
P.21 掲載の参考文献
1) Clarkson AR, Woodroffe AJ, Bannister KM, et al:The syndrome of IgA nephropathy. Cli Nephrol 21:7-14, 1984
 
2) 井川宣:抗炎症剤と腎障害. リウマチ病セミナー1(七川歡次監修), pp.272-284, 大阪, 永井書店, 1990
 
3) 野康日己:IgA腎症の臨床の実際. Medical Practice 6:1627-1630, 1989
 
4) Kitajima T, Murakami M, Sakai O:Clinicopathological features in the Japanease patients with IgA nephropathy. Jap J Med 22:219-222, 1983
 
5) Jennette JC, Wieslander J, Tuttle R, et al:Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schonlein purpura:diagnostic value and pathogenic implications. Am J Kidney Dis 18:466-471, 1991
PubMed
6) O'Donoghue DJ, Darrill A, Ballardie FW:Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schonlein purpura. J Clin Invest 88:1522-1530, 1991
PubMed
7) 荒川正昭:リウマチ腎症の臨床病理学的研究. 平成3年度厚生省リウマチ調査研究事業研究報告書 118-126, 1992
 
8) Jennette JC, Ferguson AL, Moore MA, et al:IgA nephropathy associated with soronegative spondylathropathies. Arthritis Rheum 25:144-149, 1982
 
9) Helin H, Korpela M, MustonenJ, et al:Mild mesangial glomerulopathy;A frequent finding in rheumatoid arthritis patients with hematuria or proteinuria. Nephron 42:224-230, 1986
 
10) Korpela M, Mustonen J, Helin H, et al:Immunological comparison of patients with rheumatoid arthritis with and without nephropathy. Ann Rheum Dis 49:214-218, 1990
PubMed
11) Korpela M, Mustonen J, Pastenack A, et al:Mesangial glomerulopathy in rheumatoid arthritis patients, Clinical follow-up and relation to antirheumatic therapy. Nephron 59:46-50, 1991
PubMed
12) 佐藤健比, 小澤哲夫, 菊池正俊, 他:慢性関節リウマチとIgA腎症. 腎と透析 23:411-417, 1987
 
13) Chen A, Hoy S, Tu YC, et al:Immunoglobulin A nephropathy and ankylosing spondylitis:report of two patients in Taiwan and review of the literature. Nephron 49:313-318, 1988
 
14) Peeters AJ, Warmold L, Dalsen A, et al:Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes. Ann Rheum Dis 47:645-647, 1988
 
15) Peeters AJ, Warmold L, Grietje A, et al:IgA containing immune complexes and hematuria in ankylosing spondylitis;Aprospective longitudinal study. J Rheumatol 15:1662-1667, 1988
 
16) Clarkson AR, Woodroffe AJ, Arons I, et al:IgA nephropathy. Ann Rev. Med 38:157-168, 1987
 
17) Sakai H:IgA nephropathy:recent views on pathogenesis and treatment. Nephrology(Ed, by Hatano M, et al), pp.61-71, Tokyo, Springer-Verlag, 1991
 
18) Julian BA, Waldo FB, Fifai A, et al:IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84:129-132, 1988
PubMed
19) 中澤龍司, 御手洗哲也:IgA腎症の発症機序. Medical Practice 6:1653-1655, 1989
 
20) Dohi K, Iwano M, Muraguchi A, et al:The prognostic significance of urinary interleukin 6 in IgA nephropathy. Clin Nephrol 35:1-5, 1991
PubMed
21) 野木保夫:IgA腎症. 別冊, 医学のあゆみ, 腎疾患,(成清卓二, 他編), pp.236-238, 東京, 医歯薬出版, 1992
 
P.29 掲載の参考文献
1) Kussmaul A, Maier K:Uber eine bisher nicht beschriebene eigentumliche Arterienerkrankung(Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allergemeiner Muskellahmung einhergeht. Dtsch Arch Klin 1:484-517, 1866
 
2) Zeek PM:Periarteritis nodosa:a critical review. Am J CIin Pathol 22:777, 1952
 
3) Lie JT:Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Amer 16:269-292, 1990
 
4) Lightfoot RW Jr, Michel BA, Bloch DA, et al:The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088-1093, 1990
PubMed
5) Lie JT and members and consultants of the American College of Rheumatology subcommittee on classification of vasculitis:Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 33:1074-1087, 1990
 
6) Chen KR:Cutaneous polyarteritis nodosa:a clinical and histo-pathological study of 20 cases. J Dermatol 16:429-442, 1989
 
7) Zax RH, Hodge SJ, Callen JP:Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol 126:69-72, 1990
PubMed
8) Davies DJ, Moran JE, Niall JF:Segmental necrotising glomerulonephritis with antineutrophil antibody; possible arbovinls aetiology? Br Med J 285:606, 1982
 
9) 根来茂:C-ANCAとP-ANCA. リウマチ病セミナーIV(七川歡次監修), pp.168-174, 大阪, 永井書店, 1993
 
10) Homas PB, David-Bajar KM, Fitzpatrick JE, et al:Microscopic polyarteritis. Report of a case with cutaneous involvement and antimyeloperoxidase antidodies. Arch Dermatol 128:1223-1228, 1992
 
11) Cohen Tervaert JW, Goldschmeding R, Elema JD, et al:Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33:1264-1272, 1990
 
P.36 掲載の参考文献
1) 越智隆弘:Seronegative RA. リウマチ病セミナーII(七川歡次監修), pp.43-48, 大阪, 永井書店, 1991
 
2) Kellgren JH, Bunim JJ, Bywaters EGL, et al:Possible diagnostic criteria for non-articular rheumatoid disease. In The Epidemiology of Chrinic Rheumatism(Ed, Kellgren JH, Jeffrey MR, Ball J), pp.327-328, Oxford, Blackwell Scientific Publications, 1963
 
3) Massi AT, Medsoger TA, Jr:Epidemiology of the rheumatic diseases. In Arthritis and Allied Conditions(Ed, Mc Carty DJ), pp.17-24, Philadelphia, Lea&Febiger, 1989
 
4) 七川歡次, 前田晃, 辻本正記, 他:亜急性関節リウマチについて. 臨床整形外科2:907-914, 1967
 
5) 小林茂人:扁桃腺炎に伴う反応性関節炎の臨床的考察. 第2回日本AS研究会, 大阪, 1992
 
6) McCarty DL:Treatment of early rheumatoid arthritis. In APLAR Rheumatology 1992(Ed, Nasution AK, Darmawan J, Isbagio H), pp.229-231, New York, Churchill Livingstone, 1992
 
7) McCarty DL:Clinical feature of rheumatoid arthritis. In Arthritis and Allied Conditions(Ed, Mc Carty, DJ), pp.781-809, Philadelphia, Lea&Febiger, 1993
 
8) 前田晃:回帰性リウマチは慢性関節リウマチの予備軍か?リウマチ病セミナーII(七川歡次監修), pp.80-87, 大阪, 永井書店, 1991
 
9) 大田寛:慢性関節リウマチ患者の死因と寿命. リウマチ病セミナーIII(七川歡次監修), pp.85-94, 大阪, 永井書店, 1992
 
10) Mottonen TT:Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653, 1988
PubMed
11) Young A, Corbett M, Winfield J, et al:A prognostic index for erosive changes in the hands, feet, and cervical spine in early rheumatoid arthritis. Br J Rheumatol 27:94-101, 1998
 
12) Caruso I, Santandrea S, Puttini PS, et al:Clinical laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol 17:1263-1267, 1990
 
13) Fleming A, Crown JM, Corbett, M:Prognostic value of early features in rheumatoid disease. Br Med J 1:1243-1245, 1976
PubMed
14) Lunkainen R, Isomaki H, Kajander A:Prognostic value of the type of onset of rheumatoid arthritis. Ann Rheum Dis 42:274-275, 1983
 
P.43 掲載の参考文献
1) Dawes PT, Symmons DPM:Short-term effect of anti-rheumatic drugs. Clin Rheumatol 6:117-140, 1992
 
2) Meenan RF, Gertman PM, Mason JH:Measuring health status in arthritis:the arthritis impact measurement scales. Arthritis Rheum 23:146-152, 1980
PubMed
3) Wallston KA, Brown GK, Stein MJ, et al:Comparing the short and long versions of the Arthritis Impact Measurment Scales. J Rheumatol 16:1105-1109, 1989
 
4) Pincus T, Summely JA, Sorac SA, et al:Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 30:93-96, 1983
 
5) Donnelly S, Scott DL, Emery P:The long-term outcome and justification for early treatment. Clin Rheumatol 6:141-160, 1992
 
6) Rasker JJ, Cosh JA:Long-term effects of treating rheumatoid arthritis. Clin Rheumatol 6:141-160, 1992
PubMed
7) Pincus T:The paradox of effective therapies but poor long-term outcome in rheumatoid arthritis. Semin Arthritis Rheuma 21:2-15, 1992
 
8) Scott DL, Symmons DPM, Coulton BL, et al:Long-term outcome of treating rheumatoid arthritis:results after 20 years. Lancet 1:1108-1111, 1987
 
9) Pemberton R, Peirce EG:A clinical and statistical study of chronic arthritis based on eleven hundred cases. Am J M Sci 173:31-46, 1927
 
10) Thompson HE, Wyatt BL, Hicks RA:Chronic atrophic arthritis. Ann Int Med. 11:1792-1805, 1935
 
11) Ragan C:The general management of rheumatoid arthritis. JAMA 141:125-127, 1949
 
12) Fletcher E, Lewis-Faning E:The chronic rheumatic diseases. Postgrad M J 21:176-185, 1945
 
13) Short CL & Bauer W:The course of rheumatoid arthritis in patients receiving simple medical and orthopedic measures. New Engl J Med 238(5):142-148, 1948
PubMed
14) Corrigan AB, Robinson RG, Terenty TR, et al:Benign rheumatoid arthritis of the aged. Br Med J 1:444-446, 1974
 
15) Scrinivason R, Miller BL, Paulus HE:Long-term chrysotherapy in rheumatoid arthritis, Arthritis Rheum 22:105-110, 1979
 
16) Sharp JT, Lidsky MD, Duffy J:Clinical response during gold therapy for rheumatoid arthritis. Arthritis Rheum 25:540-549, 1982
PubMed
17) Sambrook PN, Browne CD, Champion GD, et al:Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis. J Rheumatol 9:932-934, 1982
PubMed
18) Gospe SR, Spencer EM:Intramuscular gold in the treatment of rheumatoid arthritis. Clin Rheum Prac 1:173-178, 1983
 
19) Kean WF, Bellemy N, Brooks PM:Goldtherapy in the elderly rheumatoid arthritis patients. Arthritis Rheum 26:705-711, 1983
 
20) Pinals RS, Masi AT, Larsen RA, et al:Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308-1315, 1981
PubMed
21) Wolfe F, Hawley D J:Remission in rheumatoid arthritis. J Rheumatol 12:245-252, 1985
PubMed
22) Wolfe F, Howley DJ, Cathey MA:Termination of slow acting antirheumatic therapy in rheumatoid arthritis:a 14 year prospective evaluation of 1017 consecutibe starts. J Rheumatol 17:994-1002, 1990
 
23) Mottonen TT:Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653, 1988
PubMed
24) Wilke WS, Clough J D:Therapy for rheumatoid arthritis:combination of disease modifying drugs and new paradigms of treatment. Semin Arthritis Rheum 21(Suppl 1):21-34, 1991
 
25) McCarty DJ, Carrera GF:Intractabe rheumatoid arthritis:treatment with combined cyclophosphamide. azathioprine and hydroxychloroquine, JAMA 248:1718-1723, 1982
PubMed
26) Fosdick WM:Combined cytotoxic therapy in rheumatoid arthritis. Arthritis Rheum 14(Suppl):161-162, 1971
 
P.50 掲載の参考文献
1) 大里外誉郎:ヒト常在EBウイルスの感染と発がん. 東北医誌 100:239-242, 1987
 
2) Yamanishi K, Okuno T, Shiraki K, et al:Identification of human herpes virus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067, 1988
PubMed
3) 吉田正己:潜伏感染の成立と再発の機序. 単純ヘルペス, 水痘帯状庖疹, pp.108-112, メジカルトリビューン, 1991
 
4) Takahashi K, Sonoda S, Higashi K, et al:Predominant CD4 T lymphocyte tropism of human herpes virus 6-related virus. J Virol 63:3161-3163, 1989
PubMed
5) Kondo K, Kondo T, Okuno T, et al:Latent infection of human herpes virus 6 in human monocytes/macrophages. J Gen Virol 72:1401-1408, 1991
PubMed
6) 清水則夫, 高田賢蔵:ウイルスの潜伏感染. 生体防御 9:137-146, 1992
 
7) Hajar DP, Pomerant KB, Falcone DJ, et al:Herpes simplex virus infection in human arterial cells:implications in arteriosclerosis. J Clin Invest 80:1317-1321, 1987
 
8) Josephs SF, Henry B, Balachandran N, et al:HHV-6 reactivation in chronic fatigue syndrome. Lancet 337:1346-1347, 1991
PubMed
9) Saito I, Servenius B, Compton T, et al:Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 169:2191-2198, 1989
PubMed
10) 坪田一男:涙腺および角膜にみられるEBウイルスの異常発現.臨床免疫 24:386-390, 1992
 
11) Lusso P, De Maria A, Malnati M, et al:Induction of CD4 and susceptibility to HTV-1 infection in human CD8 T lymphocytes by human herpesvirus 6. Nature 349:533-535, 1991
 
12) Tsuchiya N, William RC, Hutt-Fletcher LM:Rheumatoid factors may bear the internal image of the Fcv-binding protein of herpes simplex virus type 1. J Immunol 14:4742-4748, 1990
 
13) 松田重三, 合地研吾, 後藤守孝:CFSの治療. 臨床科学 29:717-720, 1993
 
P.56 掲載の参考文献
1) Rowe IF:Arthritis in the aquired immunodeficiency syndrome and other viral infections. Current Opinion in Rheumatology 3:621-627, 1991
 
2) Rynes RI, Golednberg DL, DiGiacomo R, et al:Acquired immunodeficiency syndrome:associated arthritis. Am J Med 84:810-816, 1988
 
3) Epsonza LR, Aguilar JL, Epsinoza CG et al:HIV antigen demonstration in the synovial membrane. J Rheumatol 17:1195-1201, 1990
 
4) Hughes RA, Macatonia SE, Keat ACS, et al:The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis. Br J Rheumatol 29:166-170, 1990
 
5) Brancato L, Itescu S, Scovron ML, et al:Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection. Rheumatol Int 9:137-141, 1989
PubMed
6) Michet CJ, Machado EBV, Ballard DJ, et al:Epidemiology of Reiter's syndrome in Rochester, Minnesota:1950-1980 Arthritis Rheum 31:428-431, 1988
 
7) Epsinoza LR, Berman A, Vasey FB, et al:Psoriatic arthtitis and aquired immunodeficiency syndrome. Arthritis Rheum 31:1034-1040, 1988
 
8) Till M, MacDonell KB:Myopathy with human immunodeficiency virus type 1(HIV-1) infection:HIV-1 or zidovadine? Ann Int Med 11:492-493, 1990
PubMed
9) Valeriano-Marcet J, Ravichandran L, Kerr LD:HIV associated systemic necrotizing vasculitis. J Rheumatol 17:1091-1093, 1990
PubMed
10) Potashner W, Buskila D, Patterson BP, et al:Leukocyteclastic vasculitis with HIV infection. J Rheumatol 17:1104-1107, 1990
 
11) Buskila D, Gladman DD, Gilmore J, et al:Behcet's disease in a patient with immunodeficiency virus infection. Ann Rheum Dis 50:115-116, 1991
 
12) De Clerck LS, Couttenye MM, de Broe ME, et al:Acquired immunodeficiency syndrome mimicking Sjogren's syndrome and systemic lupus erythematosus. Arthritis Rheum 31:272-275, 1988
PubMed
13) Sokoloff L:A prospective necropsy study of arthritis in acquired immunodeficiency syndrome. Arch Pathol Lab Med 114:1035-1037, 1990
PubMed

骨関節, 脊椎, 神経

P.66 掲載の参考文献
1) Serre H, Simon L, et al:Algodystrophie extensive(du pied au rachis). Rev Rhum 35:120-124, 1968
PubMed
2) Cayla J, Rondier J:L'algodystrophie vertebrale:mythe ou realite? Rev Rhum 49:793-796, 1982
PubMed
3) Marcelli C, Herisson Ch, Simon L:Algodystrophie sympathique reflexe d'un membre inferieur avec extension au rachis. Rev Rhum 55:933-935, 1988
 
4) Doury P:L'algodystrophie du rachis. Rev Rhum 56:697-701, 1989
PubMed
5) Mitchell SW, Morehouse GR, et al:Gunshot wounds and other injuries of nerves. Philadelphia, Lippincott, 1864
 
6) Hunter J:Oeuvres completes. Vol 1:Paris, Tortin Masson, 1843
 
7) Doury P, Dirheimer Y, Pattin S:Historical review. In Algodystrophy, pp.2-6, Berlin, Springer-Verlag, 1981
 
8) Sudeck P:Uber die akute(reflektorische) Knochenatrophie nach Entzundungen und Verletzungen an den Extremitaten und ihre klinischen Erscheinungen. Fortschr Geb Roentgenstr 5:277-293, 1901-1902
 
9) 福田眞輔:Reflex sympathetic dystrophy -最近の知見-. リウマチ病セミナーIII(七川歡次監修), pp.1147-152, 大阪, 永井書店, 1992
 
10) Doury P, Dirheimer Y, Pattin S:Algodystrophy of the spine. In Algodystrophy, pp.21-23, Berlin, Springer-Verlag, 1981
 
11) Lievre JA, Hubault A:Osteoporose rachidienne et pelvienne par electrocution. Rev Rhum 28:609-611, 1951
 
12) Bacri J, Mutin S:Les manifestations osseuses du zona(a propos d'une observation) Rev. Rhum 18:618-620, 1951
 
13) Leriche R:Sur la nature de la maladie de Kummmel. Lyon Chir 27:27-28. 1930
 
14) Dequeker J, Geusens P, Verstaeten A, et al:Vertebral crush fracture syndrome and reflex sympathetic dystrophy. Bone 7:89-94, 1986
PubMed
15) Mavichak V, Murray TM, Hodsman AB, et al:Regional migratory osteoporosis. Bone 7:343-349, 1986
PubMed
16) Kozin F:Painful shoulder and the reflex sympathetic dystrophy syndrome. In Arthritis and Allied Condition(Ed, McCarty DJ), pp.1343-1346, Philadelphia, Lea and Febiger, 1985
 
P.76 掲載の参考文献
1) Netelovitz M:Estrogen replacement therapy:indications, contraindications, and agent selection. Am J Obstet Gynecol 161:1832-1841, 1989
 
2) 小松原良雄:Osteoporosisの評価法. リウマチ病セミナーI(七川歡次監修), pp.261-271, 大阪, 永井書店, 1990
 
3) 井上哲郎:骨粗鬆症の臨床像. Bone 4:39-47, 1991
 
4) Lufkin EG, Carpenter PC, Ory SJ, et al:Estrogen replacement therapy:current recommendations. Mayo Clin Proc 63:453-460, 1988
PubMed
5) 福居哲郎, 山辺徹:発癌とホルモン環境. 産科と婦人科 56:2236-2240, 1989
 
6) Riggs BL, Melton III LJ:Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899-901, 1983
 
7) Riggs BL, Melton III LJ:Involutional osteoporosis. N Engl J Med 314:1676-1686, 1986
 
8) 折茂肇, 細田祐, 白木正孝, 他:大腿骨頸部骨折全国頻度調査報告(昭和62年). 日本医事新報 3420:43-45, 1964
 
9) Jensen JS, Tondevold E:Mortality after hip fractures. Acta Orthop Scand 50:161-167, 1979
PubMed
10) Christiansen C, Christensen MS, Transbol I:Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 28:459-461, 1981
 
11) Kiel DP, Felson DT, Anderson JJ, et al:Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 317:1169-1174, 1987
PubMed
12) Weiss NS, Ure CL, Ballard JH, et al:Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195-1198, 1980
PubMed
13) Williams AR, Weiss NS, Ure CL, et al:Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obsterics & Gynecology 60:695-699, 1982
 
14) Williams SR, Frenchek B, Speroff T, et al:A study of combined continuous ethinyl and norethindrone acetate for postmenopausal hormone replacement. Am J Obstet Gynecol 162:438-446, 1990
PubMed
15) 上好昭孝, 大田喜一郎:閉経後骨粗髭症のカルシウム代謝調節ホルモンについて. 骨粗鬆症研究の進歩 6:91-97, 1990
 
16) Pilbeam CC, Klein-Nulend J, Raisz LG:Inhibition by 17β-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae. Biochem Res Commun 163:1319-1324, 1989
 
17) 中塚喜義, 西沢良記:エストロゲンとCa調節ホルモン. Bone 6:53-60, 1992
 
18) Pacifici R, Rifas L, McCracken R, et al:Ovarian steroid treatment blocks a post-menopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402, 1989
 
19) Campos H, Wilson PWF, Jimene'z D, et al:Differences in apolipoproteins and low-dencity lipoprotein subfractions in postmenopausal women on and off estrogen therapy:results from the Framingham Offspring Study. Metabolism 39:1033-1038, 1990
 
20) Gow S, MacGillivray I:Metabolic, hormonal, and vascular changes after synthetic oestrogen therapy in oophorectomized women. Br Med J 2:73-77, 1971
PubMed
21) Henderson BE, Ross RK, Paganini-Hill A, et al:Estrogen use and cardiovascular disease. Am J Obstet Gynecol 154:1181-1186, 1986
PubMed
22) Stampfer MJ, Colditz GA, Wittett WC, et al:Postmenopausal estrogen therapy and cardiovascular disease:ten-year follw-up from Nurses' Health Study. N Eng 1 J Med 325:756-762, 1991
 
23) Hammond CB, Jelovsek FR, Lee KL, et al:Effects of long-term estrogen replacement therapy. 1. Metabolic effects. Am J Obstet Gynecol 133:525-536, 1979
 
24) Wilson PWF, Garrison RJ, Castelli WP, et al:Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med 313:1038-1043, 1985
 
25) Petitti DB, Wingerd J, Pellegrin F, et al:Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. J AMA 242:1150-1154, 1979
 
26) Rosenberg L, Slone D, Shapiro S, et al:Noncontraceptive estrogen and myocardial infarction in young women. JAMA 244:339-342, 1980
PubMed
27) Busf T, Cowan LD, Barrett-Connor E, et al:Estrogen use and all-cause mortality. Preliminary results from the lipid research clinics program follw-up study. JAMA 249:903-906, 1983
 
28) Hulka BS, Grimson RC, Greenberg BG, et al:"Alternative"controls in a case-control study of endometrial cancer and exogenous estrogen. Am J Epidem 112:376-387, 1980
 
29) Smith DC, Prentice R, Thompson DJ, et al:Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164-1167, 1975
PubMed
30) Mack TM, Pick MC, Henderson BE, et al:Estrogen and endometrial cancer in a retirement community. N Engl J Med 294:1262-1267, 1976
 
31) Ziel HK, Finkle WD:Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167-1170, 1975
PubMed
32) Gray LA, Christopherson WM, Hoover RN:Estrogens and endometrial carcinoma. Obstet Gynecol 49:385-389, 1977
PubMed
33) Collins J, Donner A, Allen LH, et al:Oestrogen use and survival in endometrial cancer. Lancet II:961-963, 1980
 
34) Gambrell RD:Prevention of endometrial cancer with progestogens. Maturitas 8:159-168, 1986
PubMed
35) Perssen I, Adami HO, Bergkvist L, et al:Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens:results of a prospective study. Br Med J 298:147-151, 1989
 
36) Casagrande JT, Pike MC, Ross RK, et al:"Incessant ovulation"and ovarian cancer. Lancet II:170-173, 1979
 
37) 富永祐民:目で見る乳癌. 1. 日本における乳癌死亡, 罹患の動向. 癌の臨床. 別冊乳癌の臨床 1:102-103, 1985
 
38) McDonald TW, Anngers JF, O'Fallon WM, et al:Exogenous estrogen and endometrial carcinoma:case-control and incidence study. Am J Obstet Gynecol 127:572-580, 1977
 
39) Ross RK, Paganini-Hill A, Gerkins VR:A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243:1635-1640, 1980
PubMed
40) Criqui MH, Suarez L, Barrett-Connor E, et al:Postmenopausal estrogen use and mortality. Result from a prospective study in a defined, homogeneous community. Am J Epidemiol 128:606-614, 1988
 
41) Petitti DB, Perlman JA, Sidney S:Noncontraceptive estrogen and mortality:long-term follow-up of women in the Walnut Creek Study. Obstet & Gynecol 70:289-293, 1987
PubMed
42) Henderson BE, Paganini-Hill A, Ross RK:Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75-78, 1991
PubMed
P.86 掲載の参考文献
1) Jurik AG:Seronegative arthritides of the anterior chest wall:a follow-up study. Skeletal Rad 20:517-525, 1991
 
2) Dawes PT, Sheeran TP, Hothersall TE:Chest pain:a common feature of ankylosing spondylitis. Post graduate Med J 64;27-29, 1988
 
3) Jurik AG:Anterior chest wall involvement in seronegative arthritides. Rheumatol Int 12:7-11, 1992
PubMed
4) Van der Linden SM, Khan MS, Rentsch H-U, et al.:Chest pain without radiographic sacroiliitis in relative of patients with ankylosing spondylitis. J Rheumatol 15:836-839, 1988
 
5) Calabro JJ, Jeghers H, Millerka G, et al.:Classification of anterior chest wall syndrome. JAMA 14:1420-1421, 1980
 
6) Kayser HL:Tietze's syndrome. A review of the lilerature. Am J Med 21:982-989, 1956
PubMed
7) Levey GS, Calabro JJ:Tietze's syndrome:report of two cases and review of the literature. Arthritis Rheum 5:261-269, 1962
 
8) Jurik AG, Graudal H:Sternocostal joint swelling:clinical Tietze's syndrome. Scand J Rheumatol 17:33-42, 1988
PubMed
9) Weiner SN, Levy M, Bernstein R, Moarehouse H:Condensing osteitis of the clavicle. J Bone Joint Surg 66A:1484-1486, 1984
 
10) Fery A:La maladie de Friedrich ou osteochondrose de l'extremite sternale de la clavicule. Rev Rhum 55:141-143, 1988
 
11) Monnin JL, Pierrughes R, Bories P, et al:Le synddrome de Cyriax. Une cause d'erreur de diagnostic dans les douleurs abdominales. Press med 17:25-29, 1988
 
P.94 掲載の参考文献
1) Waldenstrom H:On necrosis of the joint cartilage by epiphyseolysis capitis femoris. Acta Chir Scand 67:936-946, 1930
 
2) Maurer RC, Larsen IJ:Acute necrosis ofcartilage in slipped capital femoral epiphysis. J Bone Joint Surg 52-A:39-50, 1970
PubMed
3) Jones BS:Adolescent chondrolysis of the hip joint. South African Med J 45:196-202, 1971
 
4) Hughes AW:Idiopathic chondrolysis of the hip:a case report and review of the literature. Ann Rheum Dis 44:268-272, 1985
PubMed
5) Lequesne M:La necrose de la tete femorale avec chondrolyse rapide. Acta Orthop Belg 38:516-525, 1972
 
6) Deshayes P, Thomine JM, Hemet J, et al:Coxopathies avec chondrolyse rapide:confrontations clinique et anatomique. Rev Rhum 42:345-353, 1975
PubMed
7) 永田善郎, 中村利孝, 鴨川盛秀ほか:Idiopathic chondrolysis of the hip:自験例および文献的考察. 臨整外 20:1201-1206, 1985
 
8) Duncan JW, Schrantz JL, Nasca RJ:The bizarre stiff hip, possible idiopathic chondrolysis. JAMA 231:382-385, 1975
PubMed
9) Bledk EE:Idiopathic chondrolysis of the hip. J Bone Joint Surg 65-A:1266-1275, 1983
 
10) van der Hoeven H, Keessin W, Kuis W:Idiopathec chondrolysis of the hip:a distinct clinical entity? Acta Orthop Scand 60:661-663, 1989
 
11) Colding JSR:Chondrolysis of the hip. J Bone Joint Surg 55-B:214-215, 1973
 
12) Duncan JW, Nasca R, Schrantz J, et al:Idiopathic chondrolysis of the hip. J Bone Joint Surg 61-A:1024-1028, 1979
PubMed
13) Mankin HJ, Sledge CB, Rothschild S, et al:Chondrolysis of the hip. In The hip. Proceedings of the third open scientific meeting of the Hip Society. St. Louis, C. V. Mosby, 1975
 
14) Wenger DR, Mickelson MR, Ponseti IV:Idiopathic chondrolysis of the hip:report of two caces. J Bone Joint Surg 57-A:268-271, 1975
 
15) Yoshioka Y, Tsuru S, Yokoyoma M, et al:Experimental study on immunological reactions against the articular cartilage. Int Archs Appl Immun 68:152-156, 1982
 
16) Daluga DJ, Millar EA:Idiopathic chondrolysis of the hip. J Pediat Orthop 9:405-411, 1989
 
17) Yoshioka Y, Tawara T, Uda H:Rapidly destructive coxarthrosis:a case report, Med J Osaka Univ 29:71-80, 1978
PubMed
18) Kahlstrom SC, Burton CC, Phemister DB:Aseptic necrosis of bone:II. Infarction of bone of undetermined etiology resulting in capsulated and calcified areas in diaphyses and in arthritis deformans. Surg Gynec Obstet 68:631-641, 1939
 
19) Rutishauser E, Taillard W:L'ischemie articulaire en pathologie humaine et experimentale;La notion de pannus vasculaire. Rev Chir Orthop 52:197-223, 1966
PubMed
20) Zahir A, Freeman MAR:Cartilage changes following a single episode of infarction of the capital femoral epiphysis in the dog. J Bone Joint Surg 54-A:125-136, 1972
 
P.101 掲載の参考文献
1) 大井洋之, 坂本和之, 波多野道信:リポジストロフィー症. 腎と透析 25:494-496, 1988
 
2) 塚原宏一, 菊池清:Congenital generalized lipodystrophyの最近の知見. 特にインスリン抵抗性糖尿病について. 小児内科 20:273-282, 1988
 
3) 脇研自, 木下修一, 藤井克範:I型高脂血症を示したCongenital generalized lipodystrophyの1例. 小児科診療 53:1362-1367, 1990
 
4) 寺山和雄:特異な病像を呈した骨の嚢腫瘍疾患の2例. 日整会誌 35:626, 1961
 
5) 那須毅:膜形成性脂質異栄養症(membranous lipodystrophy)の病理. 日病会誌 67:57-98, 1978
 
6) 那須毅:いわゆる那須病(membranous lipodystrophy)の一般病理. 神経進歩 27:239-247, 1983
 
7) Nasu T, Tsukahara Y, Terayama K:Alipid metabolic disease-"Membranous lipodystrophy"-An autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissue. Acta Path Jap 23:539-558, 1973
 
8) Hakola HPA, Jarvi OH, Sourander P:Osteodystrophia polycystica hereditaria combined with sclerosing leukodystrophy. A new entity of dementia presenile group. Acta Neurol Scand. Suppl 43:78-79, 1970
 
9) Hakola HPA, Partanen VSJ:Neurophysiolgical findings in the hereditary presenile dementia characterised by polycystic lipomembranous osteodystrophia and sclerosing leucoencephalopathy. J Neurol Neurosurg Psychiat 46:515-520, 1983
 
10) 竹島正幸, 人見泰, 木村元春, ほか:Membranous lipodystrophy(Nasu)の1剖検例. 脳神経 36:975-982, 1984
 
11) 長谷川幸治, 稲垣善幸, 渡辺鐘蔵, ほか:Membranous lipodystrophyについて, 家族内発生の2症例の報告と本邦47症例の文献的考察. 整形外科 33:1007-1016, 1982
 
12) 守田耕太郎, 田村友一, 森清幹也, ほか:那須-Hakola病の精神症状について. 2同胞例の観察から. 臨床精神医学 15:1811-1819, 1986
 
13) 三井宜夫, 宮内義純, 三浦修一:Membranous lipodystrophyの超微形態. J CIin Electron Microscopy 24:93-101, 1991
 
14) 佐藤啓三, 上畑元宏, 竹内一喜ほか:Membranous lipodystrophyの1例. 中部整災誌 28:1986-1988, 1985
 
15) Mii Y, Miyauchi Y, Yoshikawa T, et al:Ultrastructural lipid and glycoconjugate cytochemistry of membranous lipodystrophy(Nasu-Hakola disease). Virchows Archiv A Pathol Anat 419:137-142, 1991
PubMed
16) 金子和生, 田村哲男, 三木尭明, ほか:Membranous lipodystrophyの1例. 厚生年金病院年報 15:15-21, 1988
 
17) Bird TD, Koerker RM, Leaird BJ et al. Lipomembranous polycystic osteodystrophia(brain, bone, and fat disease):a genetic cause of presenile dementia. Neurology(NY) 33:81-86, 1983
 
P.112 掲載の参考文献
1) 河井秀夫, 山本浩司, 多田浩一:月状骨脱臼および周囲脱臼. 関節外科 5:885-898, 1986
 
2) Linscheid RL, Dobyns JH, Beabout JW:Traumatic instability of the wrist. Diagnosis, classification and pathomechanics. J Bone and Joint Surg 54-A:1612-1632, 1972
PubMed
3) 三浪明男:手根不安定症の病態と治療. 日整会誌 66:771-780, 1992
Medical*Online
4) 中村蓼吾, 井上五郎, 堀宗敏ほか:手根不安定症. 関節外科 5:945-957, 1986
 
5) Taleisnik J:The wrist, pp.229-238, New York, Churchill Livingstone, 1985
 

検査法

P.131 掲載の参考文献
1) 米田稔:肩関節鏡での診断. リウマチ病セミナーI(七川歡次監修), pp.223-235, 大阪, 永井書店, 1990
 
2) 田辺暁人, 山本博司, 近藤憲二ほか:腱板不全断裂に対するComputed Radiographyを用いた肩関節・肩峰下滑液包造影法. 第19回日本肩関節学会, いわき市, 1992. 10. 2-3.
 
3) 杉本勝正, 松井宣夫, 種田陽一ほか:肩腱板の画像診断-MRIと超音波検査(US)の形態的, 組織学的描出能について. 日整会誌 6(2)(3):S318, 1992
 
4) Raffi M, Firooznia H, Sherman O, et al:Rotator cuff lesions:signal patterns at MR imaging. Radiology 177:817-823, 1990
 
5) 中垣公男, 尾崎二郎, 富田恭治ほか:MR画像よりとらえた腱板の病理学的退行変性. 日整会誌 6(2)(3):S19, 1992.
 
6) Mitchel MJ, Causy GC, Berthoty DP, et al:Peribursal fat plane of the shoulder:anatomic study and clinical experience. Radiology 168:699-704, 1988
 
7) Zlatkin MB:Anatomy of the shoulder. In MRI of the Shoulder. pp.21-39 NY, Raven Press, 1991
 
8) 井澤一隆, 他:肩関節上方関節唇付着部断裂のCT関節造影所見. 第19回日本肩関節学会, いわき市, 1992. 10. 2-3
 
9) Flannigan B, Kursonogulu-Brahme S, Snyder S, et al:MR arthrography of the shoulder:comparison with conventional MR imaging. Am J Roentgenol 155:829, 1990
 
10) 岡村健司, 米田稔, 林田賢治他:腱板不全断裂に対するMRIの有用性と限界. 第19回日本肩関節学会, いわき市, 1992. 10. 2-3
 
11) Snyder SJ, et al:Partial thickness rotator cuff tears:results of arthroscopic treatment. Artroscopy 7:1-7, 1991
 
P.140 掲載の参考文献
1) Ayral X, Dougados M, Listrat V, et al:Chondroscopy:a new method for scoring chondropathy. Semin Arthritis Rheum 22:289-297, 1993
PubMed
2) Barry ME, Coelho A, Schnitzler CM, et al:Serum kerantan sulfate levels in osteoarthritis patients. Arthritis Rheum 31:648-652, 1988
 
3) 日下義章, 三船哲朗, 野口昌彦, 他:関節軟骨のMRI診断の有用性に関する基礎的研究. 関節外科 10:1049-1057, 1991
 
4) Cooper C, Cushnaghan J, Kirwan JR, et al:Radiographic assessment of the knee joint in osteoarthritis. Ann Rheum Dis 51:80-82, 1992
PubMed
5) Adams ME, wallace CJ:Quantitative imaging of osteoarthritis. Semin Arthritis Rheum 20:26-39, 1991
PubMed
6) Mazieres B, Levourc'h P, Charlet JP, et al:L'interligne radiologique dans la gonarthrose femoro-tabiale:variations en un an. In Le suivi du malade arthrosique(Vlle Jounee de Rhumatologie de l'Hopotal Cochin), pp.17-23, Paris, 1991
 
7) Laoussadi S, Menkes CJ:Amerioration de la precision de la mesure visuelle de la hauteur de l'interligne articulaire du genou et de la hanche a l'aide d'une loupe graduee. Rev du Rhum 678, 1991
 
8) Buckland-Wright JC:A new high-definition microfocal X-ray unit. Br J Radiol 62:201-208, 1989
PubMed
9) Buckland-Wright JC, Bradshaw CR:Clinical applications of high-definition microfocal radiography. Br J Radiol 62:209-217, 1989
PubMed
10) Dacre JE, Coppock JS, Herbert KE, et al:Development of a new radiographic scoring system using digital image analysis. Ann Rheum Dis 48:194-20, 1989
PubMed
11) Dacre JE, Huskisson EC:The automatic assessment of knee radiographs in osteoarthritis using digital image analysis. Br J Rheum 28:506-510, 1989
 
12) Dougados M, Nguyen M, Listrat V, et al:De la surface de l'interligne articulaire apres digitarisation des cliches radiographiques au cours de la gonarthrose femoro-tibiale. Analyse de la surface de l'interligne articulaire:286-291
 
13) Lysholm J, Hamberg P, and Gillquist J et al:The correlation between osteoarthritis as seen on radiographs and on arthroscopy. The Journal of Arthroscopic and Related Surgery 3:161-165, 1987
 
14) Brandt KD, Fife RS, Braunstein EM, et al:Radiographic grading on the severity of knee osteoarthritis:relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 34:1381-1386, 1991
 
15) Fife RS, Brandt KD, Braunstein EM, et al:Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee. Arthritis Rheum 34:377-382, 1991
PubMed
16) Rosenberg TD, Paulos LE, Parker RD, et al:The forty-five-degree posteroanterior flexion weight-bearing radiograph of the knee. J Bone Joint Surg 70-A:1479-1483, 1988
PubMed
17) 七川歡次, 西岡淳一, 米田稔, 広瀬一史, 小島保二:Voltaren arthroscopic visualisation of effect(s) on cartilage appearance in human knee OA, 1988, 未発表
 
P.147 掲載の参考文献
1) Sell S:Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. Clin Lab Med 10:1-37, 1990
PubMed
2) Schwartz MK:Advances in the use of tumor markers. Compr Ther 16:54-57, 1990
 
3) Bates SE:Clinical applications of serum tumor markers. Ann Intern Med 115:623-638, 1991
PubMed
4) Go WLW:Carcinoembryonic antigen. Clinical application. Cancer 37:562-566, 1976
 
5) 大倉久直, 岡崎伸生:CA 19-9とCA50. 内科 60:654-660, 1987
 
6) Shimomllra C, Eguchi K, Kawakami A, et al:Elevation of a tumor associated antigen CA19-9 levels in patients with rheumatic diseases. J Rheumatol 16:1410-1415, 1989
 
7) Linder J:Immunohistochemistry in surgical pathology. The case of the undifferentiated malignantneoplasm. Clin Lab Med 10:59-76, 1990
 
8) 向井万起男, 鳥潟親雄:細胞骨格(cytoskeleton)の免疫組織化学. 免疫組織化学. 病理と臨床6(臨時増刊):161-168, 1988
 
9) Gold RI, Seeger LL, Bassett LW, et al:An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am 28:471-483, 1990
 
10) 秦順一:小児腫瘍. 腫瘍マーカーの新展開-分子レベルの最新知見と病理・臨床応用の現状-. 病理と臨床 8(臨時増刊):384-397, 1990
 
11) Ushigome S, Shimoda T, Takaki K, et al:Immunocytochemical and ultrastnlctural studies of the histogenesis of Ewing's sarcoma and putatively related tumors. Cancer 64:52-62, 1989
PubMed
12) Selleri L, Hermanson GG, Eubanks JH, et al:Molecular localization of the t(11;22)(q24;q12) translocation of Ewing sarcoma by chromosomal in situ suppression hybridization. Proc Natl Acad Sci USA 88:887-891, 1991
 
13) 向井清:増殖細胞抗原. 腫瘍マーカーの新展開-分子レベルの最新知見と病理・臨床応用の現状-. 病理と臨床 8(臨時増刊):178-185, 1990
 

生物学的反応

P.160 掲載の参考文献
1) Eyre DR, Wu J-J, Woods P:Cartilage specific collagens:structural studies. In Articular cartilage and osteoarthritis(Ed, Kuettner K, et al), pp.119-131, New York, Raven Press, 1992
 
2) Eikenbery EF, Mendler M, Burgin R, et al:Fibrillar organization in cartilage. In Articular cartilage and ostenarthritis(Ed, Kuettner K, et al), pp.133-149, NewYork, Raven Press, 1992
 
3) Olsen BR:Molecular biology of cartilage collagen. In Articular cartilage and osteoarthritis(Ed, Kuettner K, et al), pp.151-165, New York, Raven Press, 1992
 
4) Fernandez MP, Selmin O, Martin GR, et al:The structure of anchorin CII, a collagenbinding protein isolated from chondrocyte membrane. J Biol Chem 263:5921-5925, 1988
 
5) Heinegart DK, Pimentel ER:Cartilage matrix protein. In Articular cartilage and osteoarthritis(Ed, Kuettner K, et al), pp.95-111, New York, Raven Press, 1992
 
6) 新名正由:軟骨代謝の生化学. リウマチ 32:85-95, 1992
 
7) Hardingham TE, Fosang A Dudhia J:Aggrecan, the chondroitin sulfate/keratan sulfate proteoglycan from cartilage. In Articular cartilage and osteoarthritis(Ed, Kuettner K, et al), pp.5-18, New York, Raven Press, 1992
 
8) Davies M, Martin J, Thomas GJ, et al:Proteinase and glomerular matrix turnover. Kidney Int 41:671-678, 1992
 
9) Werb Z:The biologic role of metalloproteinases and their inhibitors. In Articular cartilage and osteoarthritis(Ed, Keuttner K, et al), pp.295-304, New York, Raven Press, 1992
 
10) Tyler JA, Bolis S, Dingle JT, et al:Mediators of matrix catabolism. In Articular cartilage and osteoarthritis(Ed, Kuettner K, et al), pp.251-264, New York, Raven Press, 1992
 
11) Hughes C, Murphy G, Hardingham E:Metalloproteinase digestion of cartilage proteoglycan. Biochem J 279:733-739, 1991
 
12) Salowe SP, Marcy AI, Cuca GC, et al:Caracterization of zinc-binding site in human stromelysin-1:stoichiometry of the catalytic domain and identification of a cystein ligand in the proenzyme. Biochemistry 31:4525-4540, 1992
 
13) 小宮靖弘:ヒト関節滑膜における tissue inhibitor of metalloproteases(TIMP) およびstromelysinの免疫組織学的局在. 日関外誌 11:59-70, 1992
 
14) 小宮靖弘, 西岡淳一, 井上康二ほか:関節液におけるコラゲナーゼインヒビターの態様. 日関外誌 9:479-487, 1990
 
15) Firestein GS, Paine MM:Stromelysin and tissue inhibitor of metalloproteinases gene expressin in rheumatoid arthritis synovium. Am J Pathol 140:1309-1314, 1992
 
16) Okada Y, Shinmei M, Tanaka O, et al:Localization of matrix metalloproteinase 3(stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680-690, 1992
PubMed
17) Miyazaki K, Umenishi F, Funahashi, K, et al:Activation of TIMP-2/progelatinase A complex by stromelysin. Biochem Biophys Res Commun 185:859, 1992
 
P.167 掲載の参考文献
1) Thonar EJ-MA, Lenz ME, Klintworth GK, et al:Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 28:1367-1376, 1985
 
2) Sweet MBE, Coelho A, Schnitzler CM, et al:Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 31:648-652, 1988
 
3) 本吉寛, 松村文典, 永田行男, ほか:変形性膝関節症の関節液中のケラタン硫酸. 日整会誌 65:S1186, 1991
Medical*Online
4) Poole AR, Witter J, Roberts N, et al:Inflammation and cartilage metabolism in rheumatoid arthritis. Arthritis Rheum 33:790-799, 1990
PubMed
5) Witter J, Roughley PJ, Webber C, et al:The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 30:519-529, 1987
PubMed
6) Shinmei M, Inamori Y, Yoshihara Y, et al:The potential of cartilage markers in joint fluid for drug evaluation. In Articular Cartilage and Osteoarthritis(Kuettner KE, et al. eds), pp597-603, Raven Press, New York, 1992
 
7) 脇谷滋之, 越智隆弘, 大脇肇, ほか:慢性関節リウマチ患者の骨髄中多形核白血球にみられたインターロイキン1活性. 日整会誌 63:S1290, 1989
 
8) Roomy M, Symons JA, Duff GW:Interleukin-1 beta in synovial fiuid is related to local activity in rheumatoid arthritis. Rheumatol Int 10:217-219, 1990
 
9) Hovdenes J, Kvien TK, Hovdenes AB, et al:IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritis. Scand J Rheum 19:177-182, 1990
 
10) Endo H, Akahoshi T, Takagishi K, et al:Elevation of interleukin-8(IL-8) levels in joint fluids of patients with infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 10:245-252, 1991
PubMed
11) 西岡淳一:メタロプロテイナーゼとインヒビター. リウマチ病セミナーIV(七川歡次監修), pp.151-157, 大阪, 永井書店, 1993
 
P.173 掲載の参考文献
1) Davies DJ, Moran JE, Niall JF, et al:Segmental necrotizing glomerulonephritis with antineutrophil antibody:possible arbovirus aetiology? Br Med J 258:606, 1982
 
2) Van der Woude, FJ, Rasmussen N, Lobatto S, et al:Autoantibodies against neutrophils and momocytes:tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i:425-429, 1985
 
3) Falk RJ, Jennette JC:Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657, 1988
PubMed
4) Lesavre P:Antineutrophil cytoplasmic autoantibdies antigen specificity. Am J Kidney Dis 2:159-163, 1991
 
5) Cohen Tervaert JW, Van Der Woude FJ, Fauci AS, et al:Association between active Wegener's granunomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461-2465, 1989
 
6) Jennette JC:Antineurophil cytoplasmic autoantibody-associated diseases:a pathologist's perspective. Am J Kidney Dis 18:164-170, 1991
 
7) Gross WL, Schmitt WH, Csernok E:Antineutrophil cytoplasmic autoantibody-associated diseases:a rheumatologist's perspective. Am J Kidney Dis 18:175-179, 1991
 
8) Falk RJ, Terrell RS, Charles LA, Jennette C:Anti-neutroplil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119, 1990
 
9) Egner W, Chapel HM:Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitis. Clin Exp Immunol 82:244-249, 1990
PubMed
10) Cohen Tervaert JW, Huitema MG, Hene RJ, et al:Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711, 1990
 
11) Cohen Tervaert JW, Goldschmeding R, Elema JD, et al:Association of autoantibodies to myeloperoxysase with different forms of vasculitis. Arthritis Rheum 33:1264-1272, 1990
 
12) Rossi F, Jayne DRW, Lockwood CM, Katzchkine MD:Anti-idiotype against antineutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83:298-303, 1991
 
13) Kallenberg CGM, Cohen Tervaert JW, Van Der Woude FJ, et al:Autoimmunity to lysosomal enzymes:new clues to vasculitis and glomerulonephritis? Immunol Today 12:61-64, 1991
 
14) Jayne DRW, Davies MJ, Fox CJV, et al:Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337:1137-1139, 1991
 
P.180 掲載の参考文献
1) 南康博:T細胞活性化とシソグル伝達. Medical Immunology 23:105-115, 1992
 
2) Raulet DH:The stracture, function and mdecular genetics of the gamma/delta T cell receptor. Ann Rev Immunol 7:175-207, 1989
 
3) 安保徹:細菌感染とγδT細胞. Med Immunol 19:431-437, 1990
 
4) Born W, Happ MP, Dallas A, et al:Recognition of heat shock proteins and r S cell function. Immunol Today 11:40-43, 1990
 
5) 岩島牧夫:γδT細胞レパートリーの形成. Medical Immunology 21:11-201991
 
6) 志水正敏:T細胞の分類. リウマチ病セミナーI(七川歡次監修), 大阪, 永井書店, 185-193, 1990
 
7) Haas W, Kaufman S, Carols Martinez A:The development and function of gamma delta T cells. Immunol Today 11:340-343, 1990
 
8) Abbas AK, Lichitman AH, Pober JS:Bacterial 'Super-Antigens':Celluar and Molecular Immunology; Saunders Co:304 1991
 
9) 阿部雅明, 西村裕之, 広瀬幸子:T細胞抗原受容体と自己免疫疾患. Med Immunol 19:457-464, 1990
 
10) He X, Goronzy J, Weyand C:Selective induction of rthumatoid factors by superantigens and human helper T cells. J CIin Invest 89:673, 1992
 
P.187 掲載の参考文献
1) Hammer RE, Maika DS, Richardson JA, et al:Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m:an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112, 1990
 
2) Wakefield D, et al:Acute anterior uveitis and HLA-B27. Survey Ophthal 36:223-232, 1991
PubMed
3) Bjorkman PJ, Saper MA, Samraoui B, et al:Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512, 1987
PubMed
4) Buxton SE, Benjamin RJ, Clayberger C, et al:Anchoring Pockets in human histocompatibility complex leukocyte antigen(HLA) class I molecules:analysis of the coserved B("45") pocket of HLA-B27. J Exp Med 175:809-820, 1992
 
5) MacLean L, Macey M, Lowdell M, et al:Sulphydryl reactivity of the HLA-B27 epitope:accessibility of the free cysteine studied by flow cytometry. Ann Rheum Dis 51:456-460, 1992
PubMed
6) Benjamin R, Parham P:HLA-B27 and disease:a consequence of inadvertent antigen presentation? Rheum Dis Clin North Am 18:11-21, 1992
PubMed
7) Jardetzky TS, Lane WS, Robinson RA, et al:Identification of self peptides bound to purified HLA-B27. Nature 353:326-329, 1991
PubMed
8) 土屋尚之:強直性脊椎炎におけるHLA-B27と微生物抗原の意義. 臨床免疫 23:602-608, 1991
 
9) Granfors K, Isomaki H, Toivanen A:Yersinia antigens in synovial fluid cells in Yersinia-triggered reactive arthritis. N Eng J Med 320:216-219, 1989
 
10) Greamer P, Edmonds J, Sullivan J, et al:Measurement of HLA class I expression in ankylosing spondylitis. Ann Rheum Dis 51:1138-1142, 1992
 
11) Higgins CM, Lund T, Shipley ME, et al:Ankylosing spondylitis and HLA-B27:restriciton fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis. Ann Rheum Dis 51:855-862, 1992
 
12) Powis SJ, Deverson EV, Coadwell WJ, et al:Effect of polymorphism of an HLA-linked transporter on the peptides assembled in a class I molecule. Nature 357:211-215, 1992
 
P.193 掲載の参考文献
1) Kuroki Y, Shiozawa S, Fujita T, Hotta H:The contribution of human c-fos DNA to cultured synovial cells:a transfection study. J Rheumatol 20:422-428, 1993
 
2) Kuroki Y, Shiozawa S, Sugimoto T, Fujita T:Constitutive expression of c-fos gene inhibits type 1 collagen synthesis in transfected osteoblasts. Bomchem Biophys Res Commun 182:1389-1394, 1992
PubMed
3) 黒木康雄, 塩沢俊一:c-fos 遺伝子の発現と慢性関節リウマチ. 臨床免疫 25:277-284, 1993
 
4) Shiozawa S, Tokuhisa T:Contribution of synovial mesenchymal cells to the pathogenesis of joint destruction in rheumatoid arthritis. Sem Arthritis Rheum 21:267-273, 1992
 
5) 高橋祐一, 塩飽浩美, 澤井高志:慢性関節リウマチ滑膜細胞におけるproto-oncogeneの発現. 臨床免疫 23:1436-1444, 1991
 
6) Shiozawa S, Kuroki Y:Osteoporosis in rheumatoid arthritis:a molecularbiological aspect of connective tissue gene activation. Tohoku J Exp Med in press, 1993
 
7) Shiozawa S, Tanaka Y, Fujita T, Tokuhisa T:Destnlctive arthritis without lymphocyte infiltration in H 2-c-fos transgenic mice. J Immunol 148:3100-3104, 1992
 
8) Silva AJ, Paylor R, Wehner JM, Tonegawa S:Impaired special learning in a-calcium-calmodulin kinase II mutant mice. Science 257:206-211, 1992
 

治療と副作用

P.202 掲載の参考文献
1) 塩川優一, 本間光夫, 七川歡次, 他:慢性関節リウマチに対する免疫抑制剤ミゾリビンの臨床評価-基礎治療をもとにプラセボを対照薬とした多施設二重盲検比較試験. 医学のあゆみ 156:811-831, 1991.
 
2) 塩川優一, 本間光夫, 七川歡次, 他:慢性関節リウマチに対するミゾリビンの二重盲検比較試験-ロベンザリットニナトリウムを対照薬とした長期投与での多施設共同研究. 炎症 11:375-396, 1991.
 
3) McConkey B, Amos RS, Butler EP, et al:Salazopyrin in rheumatoid arthritis. Agents Actions 8/4:438-441, 1978.
PubMed
4) 西岡久寿樹, 延永正, 佐々間照(日本リウマチ財団薬効検定委員会):慢性関節リウマチに対するサラゾスルファピリジン腸溶錠(PJ-306)の二重盲検比較試験:PJ-3061g・2g/日のプラセボに対する3群比較試験. リウマチ 31:327-345, 1991.
 
5) 西岡久寿樹, 東威, 岩崎由雄(日本リウマチ財団薬効検定委員会):慢性関節リウマチに対するSalazosulfapyridin腸溶錠(PJ-306)の薬効検定-Lobenzarit disodium(CCA)を対照とした多施設二重盲検比較試験-. リウマチ 31:346-367, 1991.
 
6) 御巫清充, 西岡久寿樹, 菅原幸子, 他:慢性関節リウマチに対するサラゾスルファピリジソ腸溶錠(PJ-306)の長期投与試験基礎と臨床 25:1749-1765, 1991.
 
7) 塩川優一, 七川歓次, 延永正, 他:新しい抗リウマチ剤MS-932の慢性関節リウマチに対する臨床的検討-用量比較試験-. 臨床医薬7(Suppl 2):83-112, 1991.
 
8) 塩川優一, 七川歓次, 延永正, 他:新しい抗リウマチ剤MS-932の慢性関節リウマチに対する臨床的検討-プラセボを対照とする二重盲検比較試験-. 臨床医薬7(Suppl 2):113-147, 1991.
 
9) 塩川優一, 七川歓次, 延永正, 他:新しい抗リウマチ剤MS-932の慢性関節リウマチに対する臨床的検討-ロベンザリットニナトリウムを対照とする二重盲検試験-. 臨床医薬7(Suppl 2) 1309-1546, 1991.
 
P.208 掲載の参考文献
1) Panayi GS, Lanchburg JS, Kingsley GH:The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
 
2) Van Eden W, Holoshitz J, Nevo Z, et al:Arthritis induced by a T lymphocyte clone that responds to mycobacterium. Proc Notl Acad Sci USA 82:5117-5120, 1985
 
3) Wofsy D, Ledbetter JA, Hendler PL, et al:Treatment of murine lupus with monoclonal anti T-cell antibody. J Immunol 134:852, 1985
PubMed
4) Paulus HE, Machleder HI, Levine S, et al:Lymphocyte involvement in rheumatoid arthritis-studies during thoracic duct drainage. Arthritis Rheum 20:1249-1262, 1990
 
5) Emery P, Smith GN, Panayi GS:Lymphocytapheresis:a feasible treatment for rheumatoid arthritis. Br J Rheumatol 25:40-43, 1986
PubMed
6) Gaston JSH, Strober S, Solovera JJ, et al:Dissection of the mechanism of immune injury in rheumatoid arthrits using total lymphoid irradiation. Arthritis Rheum 31:21-29, 1988
 
7) Dougados M, Awada H, Amor B:Cyclosporin in rheumatoid arthritis:adouble blind placebo controlled study in 52 patients. Ann Rheum Dis 47:127-133, 1988
 
8) Herzog C, Walker C, Pichler W:Monoclonal anti-CD 4 in arthritis. Lancet ii:1461-1462, 1987
 
9) Kyle V, Coughlan RJ, Tighe H, et al:Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. Ann Rheum Dis:48:428-429, 1989
PubMed
10) Kirkham B, Chikanza I, Pitzalis C, et al:Response to monoclonal CD 7 antibody in rheumatoid arthritis(letter). Lancet i:589, 1988
 
11) Ortho Multicenter Transplant Study Group:A randomised clinical trial of OKT 3 monoclonal antibody for acute rejection of cadaveric renal transplant. N Engl J Med 313:337-342, 1985
 
12) Hafter DA, Fallis RJ, Dawson DM, Schlossmann SF, Reinherz EL, Weiner HL:Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody anti-T12. Neurology 36:777-784, 1986
 
13) Herzog C, Walker C, Miller W, et al:Anti-CD 4 antibody treatment of patients with rheumatoid arthritis; I. Effect on clinical course and circulating T cells. J Autoimmun 2:627-642, 1989
 
14) Reiter C, Kakavand B, Rieber EP, et al:Treatment of rheumatoid arthritis with monoclonal CD 4 antibody M-T151:clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum 34:525-536, 1991
 
15) Horneff G, Burmester GR, Emmrich F, et al:Treatment of rheumatoid arthritis with an anti-CD 4 monoclonal antibody. Arthritis Rheum 34:129-140, 1991
PubMed
16) Wedling D, Wijdenes J, Racadot E, et al:Therapeutic use of monoclonal anti-CD 4 antibody in rheumatoid arthritis. J Rheumatol 18:325-327, 1991
 
17) Goldberg D, Morel P, Chatenoud L, et al:Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmun 4:617-630, 1991
PubMed
18) Horneff G, Krause A, Emmrich F, et al:Elevated level of circulating tumor necrosis factor-α, interferon-γ, and interleukin-2 in systemic reactions induced by anti-CD 4 therapy in patients with rheumatoid arthritis. Cytokine 3:266-267, 1991
 
19) Steinman L, Rosenbaum JT, Sriran S, et al:In vivo effects of antibodies to immune reaponse gene products:prevention of experimental allergic encephalitis. Proc Natl Acad Sci USA 78:7111-7114, 1981
 
20) David CS, Banerjee S:Tcell receptor genes and disease susceptibility. Arthritis Rheum 32:105-107, 1989
 
21) Yoshino S, Cleland LG, Mayrkofer G:Treatment of collageninduced arthritis in rats with a monoclonal antibody against the α/β T cell antigen receptor. Arthritis Rheum 34:1039-1047, 1991
 
22) Jasin HE, Lightfoot E, Davis LS, et al:Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 5:541-549, 1992
PubMed
23) Riechmann L, Clark M, Waldmann H, et al:Reshaping human antibodies for therapy. Nature 332:323-327, 1988
PubMed
24) Moreland L, Bucy RP, Tilden A, et al:Use of chimeric monoclonal anti-CD 4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 36:307-318, 1993
 
P.224 掲載の参考文献
1) Nagano Y, et Kojima Y:Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets. Compt Rend Soc Bio 148:1700, 1954
 
2) Billiau A:Gamma-interferon:the match that lights the fire? Immunol Today 9:37-40, 1988
PubMed
3) Obert HJ, Hofschneider PH:Interferon for chronic rheumatoid arthritis:positive effect on clinical assessment. Dtsch med Wschr 110:1766-1769, 1985
 
4) Cannon GW, Emkey RD, Denes A, et al:Prospective two-year followup of recombinant interferon-γ in rheumatoid arthritis. J Rheumatol 17:304-310, 1990
 
5) Sprekeler R, Lemmel EM, Obert HJ:Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma, Z Rheumatol 49:1-7, 1990
PubMed
6) Hooks JJ, Moutsopoulos HM, Geis SA, et al:Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5-8, 1979
PubMed
7) Degre M, Mellbye OJ, Clarke-Jenssen O:Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis 42:672-676, 1983
PubMed
8) Cesario TC, Andrews BS, Martin DA, et al:Interferon in synovial fluid and serum of patients with rheumatic disease. J Rheumatol 10:647-650, 1983
PubMed
9) Husby G, Williams RC:Immunohistochemical studies of interleukin-2 and γ-interferon in rheumatoid arthritis. Arthritis Rheum 28:174-181, 1985
 
10) O'Kelley P, Thomsen L, Tilles JG, et al:Inactivation of interferon by serum and synovial fluids. Proc Soc Exper Biol Med 178:407, 1985
 
11) Firestein GS, Zvaifler JR:Interferon and rheumatoid arthritis. In Biologically Based Imunomodulators in the Therapy of Rheumatic Diseases.(Ed, Pincus SH, Pisetsky DS, Rossenwasser LJ), pp.369-378, New York, Elsevier, 1986
 
12) Reuter A, Bernier J, Vrindts-Gevaert Y, et al:Production of interferon gamma by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Clin Exp Rheum 6:347-354, 1988
 
13) Firestein GS, Zvaifler NJ:Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 30:864-871, 1987
 
14) Hasler F, Bluestein HG, Zvaifler NJ, et al:Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med 157:173-188, 1983
PubMed
15) Malaise MG, Franchimont P:Defective in vitro γ-interferon production in rheumatoid arthritis. Arthritis Rheum 30:230-231, 1987
 
16) Sadouk MB, Rajzbaum G, Vaquero C, et al:The defective in vitro expression of interferon-r messenger RNA in rheumatoid arthritis is recovered by cycloheximide, Cell Immunol 137:239-244, 1991
 
17) Peterlik M, Hoffmann O, Swetly P et al:Recombinant γ-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria. FEBS Lett 185:287-290, 1985
 
18) Gowen M, Mundy GR:Actions of recombinant interleukin 1, interleukin 2, and interferon-γ on bone resorption in vitro. J Immunol 136:2478-2482, 1986
 
19) Gowen M, Nedwin GE, Mundy GR:Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Min Res 1:469-474, 1986
 
20) Gowen M, MacDonald BR, Russell RGG:Actions of recombinant human r-interferon and tumor necrosis factor α on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum 31:1500-1507, 1988
 
21) Takahashi N, Mundy GR, Roodman GD:Recombinant human interferon-r inhibits formation of human osteoclast-like cells. J Immunol l 37:3544-3549, 1986
 
22) Nagasawa H, Miyaura C, Abe E, et al:Fusion and activation of human alveolar macrophages induced by recombinant interferon-γ and their suppression by dexamethasone. Am Rev Respir Dis 136:916-921, 1987
 
23) Fujii Y, Sato K, Kasono K, et al:Prolonged and ubiquitous inhibition by interferon γ of bone resorption induced by parathyroid hormone-related protein, 1, 25-dihydroxyvitamin D3, and interleukin 1 in fetal mouse forearm bones. Calcif Tissue Int 47:178-182, 1990
 
24) Granstein RD, Murphy GF, Margolis RJ, et al:Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 79:1254-1258, 1987
PubMed
25) Kahan A, Amor B, Menkes CJ, et al:Recombinant interferon-γ in the treatment of systemic sclerosis. Am J Med 87:273-277, 1989
 
26) Hein R, Behr J, Hundgen M, et al:Treatment of systemic sclerosis with r-interferon. Br J Dermatol 126:496-501, 1992
 
27) Cannon GW, Schindler JD, Emkey RD, et al:Double-blind trial of recombinant interferon-gamma versus placebo in rheumatoid arthritis. Arthritis Rheum 32:964-973, 1989
 
28) Lemmel EM, Franke M, Gaus W, et al:Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int 7:127-132, 1987
PubMed
29) Lemmel EM, Brackertz D, Franke M, et al:Results of a multicenter palcebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int 8:87-93, 1988
 
30) Muller-Fassbender H, Link F:Behandlung der chronischen Polyarthritis mit Gamma-Interferon. Abstract EULAR congress, Wien, 1985
 
31) Zilly A, Obert HJ:Therapie der chronischen Polyarthritis. Ergebnisse einer Pilot-Studie mit Lymphokinen. MUnch Med Wschr 128:87-89, 1986
 
32) Wolfe f, Cathey MA, Hawley DJ, et al:Clinical trial with γ-IFN-gamma in rheumatoid arthritis. In Biologically based immunomodulators in the therapy of rheumatic diseases(Ed, Pincus SH, Piseteskey DS, Rosenwasser LJ), pp.379-395, New York, Elsevier, 1986
 
33) Seitz M, Manz G, Franke M:Einsatz von rekombinantem Human-Interferon gamma bei Patienten. Z Rheumatol 45:93-99, 1986
PubMed
34) Veys EM, Mielants H, Verbruggen G, et al:Recombinant interferon gamma in rheumatoid arthritis. A double-blind study comparing immuneron(recombinant interferon gamma) with placebo. Clin Exp Rheumatol 5(Suppl 2):53, 1987
 
35) Veys EM, Mielants H, Verbruggen G, et al:Interferon gamma in rheumatoid arthritis:a double blind studycomparing human recombinant interferon gamma with placebo. J Rheumatol 15:570-574, 1988
 
36) Machold KP, Flener R, Smolen JS:Double-blind placebo-controlled crossover study of human recombunant gamma-interferon(gIFN) therapy in rheumatoid arthritis(RA):preliminary results. Clin Exp Rheumatol 5(Suppl 2):53, 1987
 
37) Machold KP, Neumann K, Smolen JS:Recombinant human interferon r in the treatment of rheumatoid arthritis:double bling placebo controlled study. Ann Rheum Dis 51:1039-1043, 1992
 
38) 七川歡次, 高杉潔, 塩沢和子ら:OH-6000 初期臨床第二試験成績(慢性関節リウマチ, 関西・四国地区), 大塚製薬, 1992
 
39) Ritchie DM, Boyle JA, McInnes JM, et al:Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quarterly Med, New Series XXXVII 393-406, 1968
 
40) Chazerain P, Meyer O, Ribard P, et al:Trois cas de polyarthrite survenant au cours d'un traitement par interferon-alpha recombinant. Rev Rhum 59:303-309, 1992
 
41) Ueno Y, Sohma T:Alpha-interferon-induced nodular rheumatoid arthritis in renal cell Carcinoma. Ann Intern Med 117:266-267, 1992
PubMed
42) Seitz M, Franke M, Kirchner H:Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma. Ann Rheum Dis 47:642-644, 1988
PubMed
43) Machold KP, Smolen JS:Interferon-γ induced exacerbation of systemic lupus erythematosus. J Rheumatol 17:831-832, 1990
 
44) Graninger WB, Hassfeld W, Pesau BB, et al:Induction of systemic lupus erythematosus by interferon-r in a patient with rheumatoid arthritis. J Rheumatol 18:1621-1622, 1991
 
45) Pincus SH, Cannon GW, Ward JR:In vivo administration of interferon-r to patients with rheumatoid arthritis decreases numbers of circulating B cells. J Rheumatol 17:751-757, 1990
 
46) Jacob CO, Holoshitz J, Meide PVD, et al:Heterogeneous effects of IFN-γ in adjuvant arthritis. J Immunol 142:1500-1505, 1989
 
47) Brzoska J, Obert HJ:Interferon gamma:ein januskopfiger Mediaator bei Entzundungen. Arzneim-Forsch/Drug Res 37(II):1410-1416, 1987
 
48) Shou-Nee S, Shu Fang F, Yumei W, et al:Serum interferon in systemic lupus erythematosus. Br J Dermatol 117:155-159, 1987
 
49) Von Vussow P, Jakschies D, Hartung K, et al:Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 8:225-230, 1988
 
50) Yes AMF, Yip YK, Fischer HD, et al:Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus:its association with disease activity and its independence from circulating alpha-interferon. Arthritis Rheum 33:563-568, 1990
 
51) Thivolet J, Nicolas JF, Kanitakis J, et al:Recombinant interferon alpha 2a is effective in the treatment of discoid and subacnte cutaneous erythematosus. Br J Dermatol 122:405-409, 1990
PubMed
52) O'Connell PG, Gerber LH. Digiovanna JJ. Peck GL:Arthritis in patients with psoriasis treated with gamma-interferon. J Rheumatol 19:80-82, 1992
 
53) Fielbeck G, Rassner G:Interferon-r bei Psoriasis arthropathica. Dtsch med Wschr 111:1313-1316, 1986
 
54) Pernich W, Schuchmann L, Dippell J, et al:Therapy for systemic juvenile rheumatoid arthritis with r-interferon:a pilot study of nine patients. Arthritis Rheum 32:643-646, 1989
 
P.232 掲載の参考文献
1) 平山洋二:全身性エリテマトーデスにおける消化管病変. Gastroenterol Endosc 24:405-421, 1982
 
2) 延永正, 轟木峻, 織部元広,:膠原病の消化器病変-特に慢性関節リウマチにおける消化性潰瘍について-. 温研紀要 33:174-180, 1982
 
3) 北島政樹:他疾患に合併する胃潰瘍. Medicament News 1318:33-35, 1991
 
4) 塩川優一, 延永正, 斉藤輝信, 他:非ステロイド性抗炎症剤による上部消化管傷害に関する疫学調査. リウマチ 31:96-111, 1991
 
5) 北神敬司:NSAIDs長期投与リウマチ患者の胃十二指腸病変について. 第32回日本消化器病学会大会発表, 1990 奈良
 
6) 原和人, 古田和雄, 大野健次, 他:慢性関節リウマチ患者における消化性潰瘍の検討-薬剤起因性潰瘍, 通常の消化性潰瘍との比較-. Gastroenterol Endosc 31:2089-2096, 1989
 
7) 国崎主税, 杉山貢, 土屋周二:慢性関節リウマチに合併する胃病変の検討-免疫組織学的検討を加えて-Therapeutic Research 12:1331-1339, 1991
Medical*Online
8) 菊池正敏, 佐藤健比呂, 中野正明, 他:慢性関節リウマチの消化器病変-とくに上部消化管について-. リウマチ 31:374-380, 1991
 
9) Hollander D:Gastrointestinal complications of non steroidal anti-inflammatory drugs. 第2回欧州連合消化器病週間講演集, 1992アテネ
 
10) 寺野彰, 太田慎一, 武藤弘行:NSAIDs 起因性胃十二指腸病変. 内科 66:246-249, 1990
 
11) Price AH, Fletcher M:Mechanisms of NSAID-induced gastroenteropathy. Drugs 40:1-11, 1990
PubMed
12) 寺野彰, 太田慎一, 秦康夫, 他:NSAIDs起因性胃病変の発生と防御因子. 臨床消化器内科 6:1743-1749, 1991
 
13) 芳野純治, 中澤三郎, 山雄健次, 他:ステロイドと上部消化管病変. 臨床消化器内科 6:1763-1769, 1991
 
14) 前田淳, 石川雅枝, 重本六男, 他:薬剤性胃病変の発生予防における防御因子増強剤併用の意義. 薬の知識 41:21-26, 1990
 
15) 小林絢三, 荒川哲男:NSAIDs起因性上部消化管病変の治療と予防. 臨床消化器内科 6:1751-1762, 1991
 
16) Graham DY, Agrawal NM, Roth SH:Prevention of NSAID-induced gastric ulcer with misoprostol:multicentre, double-blind placebo-controlled trial. Lancet 3:1277-1280, 1988
PubMed
17) 塩川優一, 延永正, 斉藤輝信, 他:非ステロイド性抗炎症剤(NSAIDs) 長期投与時にみられる胃・十二指腸潰瘍に対するミソプロストールの臨床的有用性の検討-第1報・プラセボ対照二重盲検比較試験法による粘膜防御効果の検討-. リウマチ 31:554-571, 1991
 
18) Ehsanullah RSB, Page MG, Tildeslay G, et al:NSAID-induced gastroduodenal damage:effect of ranitidine prophylaxis. Gastroenterology 94:A111, 1988
 
19) Robinson MG, et al:Effects of rantidine gastroduodenal mucosal damage induced by non-steroidal anti-inflammatory drugs. Dig Dis Sci 34:424, 1989
 
20) 小林絢三, 水島裕, 柳川明, 他:非ステロイド性抗炎症剤による胃・十二指腸病変に対するH2受容対拮抗剤ranitidineの予防効果. 臨床成人病 20:253-264, 1990
 
21) 塩川優一, 延永正, 斉藤輝信, 他:非ステロイド性抗炎症剤(NSAIDs) 長期投与時にみられる胃・十二指腸潰瘍に対するミソプロストールの臨床的有用性の検討-第2報・NSAID 継続投与下における潰瘍治療効果の検討-. リウマチ 31:572-582, 1991
 
P.244 掲載の参考文献
1) Borel JF, Feurer C, Gubler JU, et al:Biological effects of cyclosporin A:a new antilymphotic agents. Agents Actions 6:468-475, 1976
 
2) Calne RY, White DJG, Thiru S, et al:Cyclosporin A in patients receiving renal allografts from cadaverdoners. Lancet ii:1323-1327, 1978
 
3) Shand N, Richardson B:Sandimmun(Cyclosporin A):Mode of action and clincal results in rheumatoid arthritis. Scand J Rheumatology 76(Suppl.):265-278, 1988
 
4) Hess AD, Tutschka PJ, Santos GW, et al:Effect of cyclosporin A on human lymphocyte responses in vitroinduction of tolerance to alloantigens. Transplant Proc 13:374-378, 1981
PubMed
5) Leapman SB, Filo RS, Smith EJ, et al:In vitro effects of cyclosporin A on lymphocyte. Transplantation 30:404-408, 1980
PubMed
6) Kahan, BD:Cylosporine. N. Engl. J Med 321, 1725-1738, 1989.
 
7) Hess AD, Colombani PM:Mechanism of action in vitro studies. Prog Allergy 38:198-221, 1986
PubMed
8) Borel JF:Immunosuppression:Building on Sandimmune(Cyclosporine). Transplant Proc 20:149-153, 1988
PubMed
9) Russel RGG, Graveley R, Coxon F, et al:Cyclosporin A. Mode of action and effects of bone and joint tissues. Scand J Rheumatol 21(Suppl 95):9-18, 1992
 
10) Yocum D:Immunological actions of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 32(Suppl 1):38-41, 1993
 
11) Russell RGG, Graveley R, Skjodt H:The effects of cyclosporin A on bone and cartilage. Br J Rheumatol 32(Suppl 1):42-46, 1993
 
12) Hermann B, Muller W:Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunsuppressivum. Akt Rheumatol 4:173-186, 1979
 
13) Amor B, Dougados M:Cyclosporin in rheumatoid arthiris;Open trials with different dosages. In Cyclosporin in Autoimmune Diseases(Ed, Schindler R), pp, 283-287, Berlin, Springer-Verlag, 1985
 
14) Madhok R, Capell H:Cyclosporin A;A potential disease modifying drug in rheumatoid arthritis. Arthritis Rheum 28:S68, 1985(Suppl:absr)
 
15) Dougados M, Amor B:Cyclosporin A in rheumatoid arthritis:preliminary clinical results of an open trial. Arthritis Rheum 30:83-86, 1987
PubMed
16) Weinblatt ME, Coblyn JS, Fraser PA:Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum 30:11-17, 1987
PubMed
17) Bowles CA:Long-term treatment of rheumatoid arthritis with cyclosporin(CsA). Arthritis Rheum 32:S61, 1987(abstr)
 
18) Tugwell P, Bombardier C, Gent M, et al:Low dose cyclosporine in rheumatoid arthritis:a pilot study. J Rheumatol 14:1108-1114, 1987
PubMed
19) Dougados M, Duchesne L, Awada H, et al:Assessment of efficacy and acceptability of low dose cyclosporine in patients with rheumatoid arthritis. Ann Rhuem Dis 48:550-556, 1989
PubMed
20) 吉野谷定美, 宮本昭正:シクロスポリンの慢性関節リウマチに対する臨床試験. 炎症 10:301-307, 1990
Medical*Online
21) Forre O, Bjerkhoel F, Salvesem CF, et al:An open controlled randomized comparison of cyclosporine and azathioprine in the rheumatoid arthritis:a preliminary report. Arthritis Rheum 30:88-92, 1987
 
22) Yocum E, Klippel JH, Wilder RL, et al:Cyclosporine A in severe, treatment-refractory rheumatoid arthritis. Ann Intern Med 109:863-869, 1988
 
23) van Rijthoven AWAM, Dikjmans BAC, Goeithe HS, et al:Cyclosporine treatment for rheumatoid arthritis:a placebo-controlled double-blind multicentre study. Ann Rheum Dis 45:726-731, 1986
 
24) Dougados M, Awada H, Amor B:Cyclosporine in rheumatoid arthritis:a double blind, placebo contorolled study in 52 patients. Ann Rheum Dis 47:127-133, 1988
 
25) Tugwell P, Bombardier C, Gent M, et al:Low dose cyclosporine versus placebo in patients with rheumatoid arthritis. Lancet 335(8697):1051-1055, 1990
PubMed
26) Gottrand O, Largilliere C, Farriaux JP:Cicrosporine neurotoxicity. N Engl J Med 324:11744-1745, 1991
 
27) Lin HY, Rocher LL, McQuillan MA, et al:Cicrosporine-induced hyperuricemia and gout. N Engl J Med 321:287-292, 1989
 
28) Lucas V, Hourmant M, Soulillou J-P, et al:Douleurs osseuses epiphysaires rapportees a la ciclosporine A chez 28 transplantes renaux. Rev Rhum 57:79-84, 1990
 
29) Munoz-Gomez J, Collado A, Gratacos J, et al:Reflex sympathetic symdrome of the lower limbs in renal transplant patients treated with cyclosporin A. Arthritis Rheum 34:625-630, 1991
 
30) Chassagne P, Mejjad O, Moore N, et al:Myopathy as possible side-effect of ciclosporin. Lancet 2, 1104, 1989
PubMed
31) Fernandez-Sola J, Campistol J, Cassdemont J, Gran JM, Urbano-Marquez A:Reversible ciclosporin myopathy. Lancet 335:362-363, 1990
 
32) van Rijthonven AWAM, Dikjmans BAC, Goeithe HS, et al:Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis;A randomized double-blind study. J Rheumatol 18:815-820, 1991
 
33) Bombardier C, Buchbinder R, Tugwell P:Efficacy of cyclosporin A in rhuematoid arthritis:long-term follow-up data and the effect on quality of life. Scand J Rheumatol 21(Suppl 95):29-33, 1992
 
34) Wells G, Tugwell P:Cyclosporin A in rheumatoid arthritis:overview of efficacy. Br J Rheumatol 32(Suppl 1):51-56, 1993
 
35) Dougados M, Torley H:Efficacy of cyclosporin A in rheumatoid arthritis:worldwide experience. Br J Rheumatol 32(Suppl 1) 57-59, 1993
 
36) 近藤啓文:免疫抑制剤(RA 治療における有用性). 医学のあゆみ 161:694-698, 1992
 
37) A consensus report:cyclosporine for psoriasis. Safety guidelines for cyclosporine therapy in psoriasis. Br J Dermt 122:1-3, 1990
 
38) 増田寛次郎, 林清文:ベーチェット病におけるシクロスポリン療法の治療方針作成の試みと最近の成績. 厚生省特定疾患ベーチェット病調査研究班, ベーチェット病に関する研究, 昭和61年度研究業績, pp.276-279, 1986
 
39) Nussenblatt RB, Palestine AG, Rook AH, et al:Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 2:235-238, 1983
PubMed
40) 赤沢和美, 溝渕京子, 秋谷綾子, 他:難治性ベーチェット病に対するCyclosporin A 療法. 臨床眼科 38:393-397, 1984
 
41) 大野重昭, 津田久仁子, 吉田篤, 他:ベーチェット病に対するCyclosporin A 療法. 厚生省特定疾患ベーチェット病調査研究班, ベーチェット病に関する研究, 昭和59年度研究業績, pp.264-270, 1984
 
42) 増田寛次郎, 林清文, 中川和美:ベーチェット病のCyclosporin Aによる長期治療. 厚生省特定疾患ベーチェット病調査研究班, ベーチェット病に関する研究, 昭和59年度研究業績, pp.271-276, 1984
 
43) Feutren G, Querin S, Noel LH, et al:Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 111:1063-1068, 1987
PubMed
44) Ostensen M, Hoyeraal HM, Kass E:Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. J Rheumatol 15:1536-1538, 1988
PubMed
45) Gupta AK. Matteson EL, Ellis CN, et al:Ciclosporine in the treatment of psoriatic arthritis. Arch Dermatol 125:507-510, 1989
PubMed
46) Anstey A, Mayou S, Morgan K, Clague RB, Munro DD:Relapsing polychondritis:autoimmunity to type II collagen and treatment with ciclosporin A. Br J Dermatol 125:589-591, 1991
 
47) Heckmatt J, Hasson N, Saunders C, et al:Ciclosporin in juvenile dermatomyositis. Lancet 1:1063-1066, 1989
PubMed
48) Levi S, Hodgson HJF:Ciclosporin for dermatomyositis? Ann Rheum Dis 48:85-86, 1989
 
49) Knop J, Bonsmann G:Cyclosporine in the treatment of progressive systemic sclerosis. In Cyclosporine in Autoimmune Diseases(Ed, Schindler R), pp.199-200, New York, Springer-Verlag, 1985
 
P.251 掲載の参考文献
1) Bracken MB, Collins WF, Freeman DF, et al:Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251:45-52, 1984
PubMed
2) Bracken MB, Shepard MJ, Hellenbrand KG, et al:Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 63:704-713, 1985
PubMed
3) Demopoulos HB, Flamm ES, Pietronigro DD, et al:The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand 492(Suppl):91-119, 1981
 
4) Hall ED:Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma 8(Suppl) 31-40, 1991
 
5) Hall ED:The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76:13-22, 1992
PubMed
6) Bracken MB, Shepard MJ, Collins WF, et al:A randomized, controlled trial of methylprednisolone or nalexone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. New Engl J Med 32:1405-1411, 1990
 
7) Bracken MB, Shepard MJ, Collins WF, et al:Methylprednisolone or naloxone treatment after acute spinal cord injury:1-year follow-up data. Results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 76:23-31, 1992
 
8) Hall ED, Yonkers PA, Andrus PK, et al:Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 9(Suppl):425-442, 1992
 

手術

P.269 掲載の参考文献
1) Kapandji IA:The shoulder. In The physiology of the joints(5th ed, translated by Honore LH), Vol 1 Upper limb, pp.1-71, Edinburgh, Churchill Livingstone, 1982
 
2) Himeno S, Tsumura H:The role of rotator cuff as a stabilizing mechanism of the shoulder. In Surgery of the shoulder(Ed, Bateman JE, Welsh RP), pp.17-21, Burlington, BC Decker, 1984
 
3) 小川亮恵:リウマチの上肢の手術. 関節外科 9:731-737, 1990
 
4) Walch G, Noel E, Guier C, et al:Rheumatoid arthritis of the shoulder:a review of 250 patients. In Surgery of the shoulder(Ed, Post M et al), pp.267-269, St Louis, Mosby-Year Book, 1990
 
5) 信原克哉:肩-その機能と臨床(第2版). 医学書院, 東京, 1987
 
6) Jenkins DB:The shoulder. In Hollinshead's functional anatomy of the limbs and back(6th ed), pp.65-101, Philadelphia, Saunders, 1991
 
7) 西林保朗, 八木範彦:RA上肢における肩関節. 第7回関西リウマチ学会で発表, 1993
 
8) Friedman RJ:Biomechanics of the shoulder following total shoulder replacement. In Surgery of the shoulder(Ed, Post M et al), pp.263-266, St Louis, Mosby-Year Book, 1990
 
9) Crossan JF, Vallance R:The shoulder joint in rheumatoid arthritis. In Shoulder surgery(Ed, Bayley I, Kessel L), pp.131-139, Berlin, Spinger-Verlag, 1982
 
10) Neer II CS:Glenohumeral arthroplasty. In Shoulder reconstruction, pp.143-271, Philadelphia, Saunders, 1990
 
11) Lettin AWF, Pettersson C(Ed.):Rheumatoid arthritis surgery of the shoulder. Basel, Karger, 1989
 
12) Wolff R, Kolbel R:肩関節置換術の歴史. 肩の人工関節(Ed, Kolbel Rら, 平澤泰介訳), pp.3-14, 東京, シュプリンガー・フェアラーク東京, 1988
 
13) 塚西茂昭, 信原克哉:リウマチ肩の再建手術. リウマチ学(塩川優一監修), pp.1351-1356, 東京, 同文書院, 1989
 
14) Wallace WA:The Nottingham Dacron hood reinforcement for unconstrained shoulder replacement. In Surgery of the shoulder(Ed, Post M et al), pp.277-281, 1990.
 
15) 渡辺弘, 氏家秀夫, 広畑和, 志:人工関節のアメリカ市場の調査について. 平成3年度厚生省リウマチ調査研究事業研究報告書, pp.258-259, 1992
 
16) Cofield RH, Edgerton BC:Total shoulder arthroplasty:complications and revision surgery. In American Academy of Orthopaedic Surgeons Instructional Course Lectures, XXXIX(Ed, Greene WB), pp.449-462, Park Ridge, AAOS, 1990
 
17) Figgie III HE, Inglis AE, Goldberg VM, et al.:An analysis of factors affecting the longterm results of total shoulder arthroplasty in inflammatory arthritis. J Arthroplasty 3:123-130, 1988
 
18) Hirst P, Wallace WA:Poor results of Neer shoulder replacement in rheumatoid arthritis. In The shoulder(Ed, Takagishi N), pp.362-366, Tokyo, Professional Postgraduate Services, 1987
 
19) McCoy SR, Warren RF, Bade III HA, et al:Total shoulder arthroplasty in rheumatoid arthritis. J Arthroplasty 4:105-113, 1989
 
20) Thomas BJ, Amstutz HC, Cracchiolo A:Shoulder arthroplasty for rheumatoid arthritis. Clin Orthop 265:125-128, 1991
PubMed
21) Swanson AB:Bipolar implant shoulder arthroplasty. In Rheumatoid arthritis surgery of the shoulder(Ed, Lettin AWF, Pettersson C), pp.103-123, Basel, Karger, 1989
 

書評

最近チェックした商品履歴

Loading...